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Commission’s Amended Order Enables Adult-Use Operators to Support
Supply Chain for Medical Use of Marijuana Program
General adult-use operations remain closed until May 4; all licensees will be
required to report con rmed COVID-19 cases to the agency
WORCESTER—The Cannabis Control Commission (Commission) issued an
amended cease and desist order Tuesday pursuant to the Baker
Administration’s extended stay-at-home advisory and emergency order that
Commission’s Amended Order
Enables Adult-Use Operators to
Support Supply Chain for Medical
Use of Marijuana Program
COMMONWEALTH OF MASSACHUSETTS
will enable certain Marijuana Establishments (ME) and Colocated Marijuana
Operations (CMO) to support the medical marijuana supply chain.
The amended order became e ective at 12 p.m. on Tuesday, April 7 and lasts
until at least 12 p.m. on Monday, May 4 unless otherwise extended, amended,
or rescinded. The update acknowledges the ongoing non-essential status of
adult-use cannabis operations and essential status of medical-use
operations under the Baker Administration’s order. Additionally, it cites the
158% increase in patient applications and more than 30 telehealth
certi cation waivers the Medical Use of Marijuana Program has received
since the Governor’s essential services order was  rst issued on March 23.
Anticipating increases in patient demand during the Commonwealth’s state
of emergency and recognizing the percentage of adult-use inventory that
traditionally supports both the adult- and medical-use markets, the new
order will enable adult-use operators to complete wholesale transfers of
existing adult-use marijuana and marijuana products to a CMO and/or
Medical Marijuana Treatment Center (MTC) when needed to support
continued manufacturing functions within the medical marijuana supply
chain. The transfer of marijuana and marijuana products between MEs and
MTCs is a common business practice within the industry. When a
documented emergency occurs, transfers are permitted under the
Commission’s current regulations as long as licensees protect patient supply
and record them in the state’s seed-to-sale tracking system.
Prior to a transfer, the recipient CMO or MTC is required to submit an
attestation to the Commission regarding the medical supply need that will be
met by the adult-use product. Upon receiving the inventory, the CMO or MTC
must immediately transfer the product to their medical license and ensure it
will be reserved for medical use until it is dispensed or destroyed. All
products must comply with the Commission’s labeling and packaging
requirements under the medical use of marijuana regulations before they can
be sold.
The Commission also will permit MEs and CMOs that operate adult-use
cultivation facilities, including Cultivators, Microbusinesses, and Craft
Marijuana Cooperatives, to designate necessary sta  to maintain operations
in accordance with the Baker Administration’s order. Essential cultivation
operations include feeding and irrigating existing plantings, undertaking pre-
existing integrated pest management and preventative maintenance
programs, and harvesting, drying, curing, and storing existing plants. Adult-
use operators will be authorized to make new cultivation plantings, transfer
un nished harvested marijuana, and process harvested marijuana into newly
 nished products upon demonstrating that those operations are necessary to
support the medical marijuana supply chain. Independent Testing
Laboratories may test adult-use products that licensees attest will be
transferred to medical supply.
Following a series of bulletins the Commission has issued since March 13 to
assist licensees with ensuring, preserving, and promoting public health within
their facilities during the COVID-19 state of emergency, the new order takes
the Commission’s commitment to safety another step further. In addition to
adhering to Administration and US Centers for Disease Control and
Prevention (CDC) protocols regarding safety and COVID-19 reporting,
licensees will now be required to notify the Commission of an employee
work-related illness resulting in a con rmed COVID-19 case within twenty-
four hours of having actual knowledge.
Licensees must continue to monitor and comply with all Commission
bulletins as well as guidelines issued by the Governor, the Commission, the
Department of Public Health, local authorities, and the CDC, including those
establishing social distancing, environmental cleaning, and disinfection
measures. Agents who believe they are working in unsafe conditions or must
continue working when non-essential may  le a complaint with the
Commission at Commission@CCCMass.Com with subject line “COVID-19
Agent Complaint.” Complaints may be submitted anonymously. Licensees
and agents must follow all applicable employment laws, including laws
against unlawful retaliation. The Commission continues to look into
complaints and maintains enforcement mechanisms to support compliance.
For more information, visit the Commission’s COVID-19 Updates page at
MassCannabisControl.Com, contact the Commission by phone (774-415-
0200) or email (Commission@CCCMass.Com), or follow the agency on
Facebook and Twitter.
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